| 0.4347 0.001 (0.16%) | 06-25 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.51 | 1-year : | 0.6 |
| Resists | First : | 0.43 | Second : | 0.51 |
| Pivot price | 0.42  |
|||
| Supports | First : | 0.41 | Second : | 0.4 |
| MAs | MA(5) : | 0.42 |
MA(20) : | 0.42 |
| MA(100) : | 0.33 |
MA(250) : | 0.54 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 85.6 |
D(3) : | 86.7 |
| RSI | RSI(14): 65.1 |
|||
| 52-week | High : | 1.25 | Low : | 0.19 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AKLI ] has closed It is unclear right now based on current values. 86.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.44 - 0.44 | 0.44 - 0.44 |
| Low: | 0.43 - 0.43 | 0.43 - 0.43 |
| Close: | 0.43 - 0.43 | 0.43 - 0.44 |
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Thu, 20 Jun 2024
Financial Comparison: Akili (NASDAQ:AKLI) and Tandem Diabetes Care (NASDAQ:TNDM) - Defense World
Fri, 14 Jun 2024
AKILI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC ... - PR Newswire
Thu, 06 Jun 2024
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Marathon Oil ... - GlobeNewswire
Tue, 04 Jun 2024
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its ... - PR Newswire
Mon, 03 Jun 2024
AKLI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akili, Inc. Is Fair to Shareholders - Manchestertimes
Tue, 14 May 2024
Akili Reports First Quarter 2024 Financial Results and Provides Business Update - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 79 (M) |
| Held by Insiders | 2.151e+007 (%) |
| Held by Institutions | 23.2 (%) |
| Shares Short | 80 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -5.593e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 836.8 % |
| Return on Equity (ttm) | -36.7 % |
| Qtrly Rev. Growth | 1.95e+006 % |
| Gross Profit (p.s.) | 138.89 |
| Sales Per Share | -39.57 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -0.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -49 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.02 |
| Price to Cash Flow | 1.16 |
| Dividend | 0 |
| Forward Dividend | 487680 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|